Assessing antiviral potency of anti-HIV therapies in vivo by comparing viral decay rates in viral dynamic models.
暂无分享,去创建一个
[1] P. Diggle,et al. Analysis of Longitudinal Data. , 1997 .
[2] Alan S. Perelson,et al. Decay characteristics of HIV-1-infected compartments during combination therapy , 1997, Nature.
[3] E. Vonesh,et al. Linear and Nonlinear Models for the Analysis of Repeated Measurements , 1996 .
[4] D. R. Kuritzkes,et al. HIV viral load markers in clinical practice , 1996, Nature Medicine.
[5] H Wu,et al. Population HIV‐1 Dynamics In Vivo: Applicable Models and Inferential Tools for Virological Data from AIDS Clinical Trials , 1999, Biometrics.
[6] A A Ding,et al. Relationships between antiviral treatment effects and biphasic viral decay rates in modeling HIV dynamics. , 1999, Mathematical biosciences.
[7] A. Perelson,et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection , 1995, Nature.
[8] L. Skovgaard. NONLINEAR MODELS FOR REPEATED MEASUREMENT DATA. , 1996 .
[9] J. Mellors,et al. Quantitation of HIV-1 RNA in Plasma Predicts Outcome after Seroconversion , 1995, Annals of Internal Medicine.
[10] M. R. Novick,et al. The Role of Exchangeability in Inference , 1981 .
[11] M A Nowak,et al. Viral dynamics in vivo: limitations on estimates of intracellular delay and virus decay. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[12] A. Perelson. Modeling the interaction of the immune system with HIV , 1989 .
[13] A S Perelson,et al. Rate of HIV‐1 decline following antiretroviral therapy is related to viral load at baseline and drug regimen , 1998, AIDS.
[14] V. Gruttola,et al. Why are the decay rates in plasma HIV-1 different for different treatments and in different patient populations? , 1999, AIDS.
[15] E. Spjøtvoll,et al. Plots of P-values to evaluate many tests simultaneously , 1982 .
[16] Alan S. Perelson,et al. Mathematical Analysis of HIV-1 Dynamics in Vivo , 1999, SIAM Rev..
[17] Lee-Jen Wei,et al. Combining dependent tests with incomplete repeated measurements , 1985 .
[18] Martin A. Nowak,et al. Viral dynamics in human immunodeficiency virus type 1 infection , 1995, Nature.
[19] John Wishart,et al. GROWTH-RATE DETERMINATIONS IN NUTRITION STUDIES WITH THE BACON PIG, AND THEIR ANALYSIS , 1938 .
[20] A. Perelson,et al. HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time , 1996, Science.
[21] John W. Mellors,et al. Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma , 1996, Science.
[22] P. Diggle,et al. Analysis of Longitudinal Data , 2003 .
[23] V De Gruttola,et al. Estimation of HIV dynamic parameters. , 1998, Statistics in medicine.
[24] P. O'Brien. Procedures for comparing samples with multiple endpoints. , 1984, Biometrics.
[25] J F Boisvieux,et al. Alternative approaches to estimation of population pharmacokinetic parameters: comparison with the nonlinear mixed-effect model. , 1984, Drug metabolism reviews.
[26] J. G. Rowell,et al. Analysing data with repeated observations on each experimental unit , 1976, The Journal of Agricultural Science.